A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

NCT04916002 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

77

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision related to study drug supply

Conditions

Merkel Cell Carcinoma
Cutaneous Squamous Cell Carcinoma
Basal Cell Carcinoma
Triple Negative Breast Cancer
Non-Small Cell Lung Cancer
Oropharynx Squamous Cell Carcinoma

Interventions

DRUG: vidutolimod
DRUG: cemiplimab

Sponsor

Regeneron Pharmaceuticals